StockData
PERRIGO Co plc logo

PERRIGO Co plc (PRGO) stock

PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3010% below fair value
$16.94+1.18 (+7.49%)

Close on Nov 18, 2026Market cap $2.35BP/E –Yield 6.85%

Perrigo revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Perrigo's revenue for the twelve months ending Jun 27, 2026 was $4.14B, down 4.2% year over year. For fiscal 2025 it was $4.25B, down 2.8% from the year before. Over ten years it grew 0.8% a year on average. The highest annual figure on record is $4.95B in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.25B-2.8%
FY2024Dec 31, 2024$4.37B-6.1%
FY2023Dec 31, 2023$4.66B+4.6%
FY2022Dec 31, 2022$4.45B+7.6%
FY2021Dec 31, 2021$4.14B+1.2%
FY2020Dec 31, 2020$4.09B+5.6%
FY2019Dec 31, 2019$3.87B-18.2%
FY2018Dec 31, 2018$4.73B-4.3%
FY2017Dec 31, 2017$4.95B+17.0%
FY2015Jun 27, 2015$4.23B+8.0%
FY2014Jun 28, 2014$3.91B+489162.5%
FY2013Jun 29, 2013$800.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 27, 2026$1.02B-3.2%
Q1 FY2026CQ1 2026Mar 28, 2026$969.20M-7.2%
Q4 FY2025CQ4 2025Dec 31, 2025$1.11B-2.5%
Q3 FY2025CQ3 2025Sep 27, 2025$1.04B-4.1%
Q2 FY2025CQ2 2025Jun 28, 2025$1.06B-0.9%
Q1 FY2025CQ1 2025Mar 29, 2025$1.04B-3.5%
Q4 FY2024CQ4 2024Dec 31, 2024$1.14B-1.6%
Q3 FY2024CQ3 2024Sep 28, 2024$1.09B-3.2%
Q2 FY2024CQ2 2024Jun 29, 2024$1.07B-10.7%
Q1 FY2024CQ1 2024Mar 30, 2024$1.08B-8.4%
Q4 FY2023CQ4 2023Dec 31, 2023$1.16B+0.1%
Q3 FY2023CQ3 2023Sep 30, 2023$1.12B+2.1%
Q2 FY2023CQ2 2023Jul 1, 2023$1.19B+6.4%
Q1 FY2023CQ1 2023Apr 1, 2023$1.18B+10.0%
Q4 FY2022CQ4 2022Dec 31, 2022$1.16B+4.6%
Q3 FY2022CQ3 2022Oct 1, 2022$1.10B+5.5%
Q2 FY2022CQ2 2022Jul 2, 2022$1.12B+14.3%
Q1 FY2022CQ1 2022Apr 2, 2022$1.07B+6.4%
Q4 FY2021CQ4 2021Dec 31, 2021$1.10B-14.3%
Q3 FY2021CQ3 2021Oct 2, 2021$1.04B+4.0%
Q2 FY2021CQ2 2021Jul 3, 2021$981.10M+3.4%
Q1 FY2021CQ1 2021Apr 3, 2021$1.01B-6.8%
Q4 FY2020CQ4 2020Dec 31, 2020$1.29B-2.5%
Q3 FY2020CQ3 2020Sep 26, 2020$1.00B-15.8%
Q2 FY2020CQ2 2020Jun 27, 2020$948.80M-17.4%
Q1 FY2020CQ1 2020Mar 28, 2020$1.08B-7.8%
Q4 FY2019CQ4 2019Dec 31, 2019$1.32B+10.7%
Q3 FY2019CQ3 2019Sep 28, 2019$1.19B+5.1%
Q2 FY2019CQ2 2019Jun 29, 2019$1.15B-3.2%
Q1 FY2019CQ1 2019Mar 30, 2019$1.17B-3.5%
Q4 FY2018CQ4 2018Dec 31, 2018$1.20B-6.8%
Q3 FY2018CQ3 2018Sep 29, 2018$1.13B-8.0%
Q2 FY2018CQ2 2018Jun 30, 2018$1.19B-4.2%
Q1 FY2018CQ1 2018Mar 31, 2018$1.22B+1.9%
Q4 FY2017CQ4 2017Dec 31, 2017$1.28B-9.3%
Q3 FY2017CQ3 2017Sep 30, 2017$1.23B+27.3%
Q2 FY2017CQ2 2017Jul 1, 2017$1.24B–
Q1 FY2017CQ1 2017Apr 1, 2017$1.19B–
Q4 FY2015CQ2 2015Jun 27, 2015$1.42B–
Q3 FY2015CQ1 2015Mar 28, 2015$967.20M–

More Perrigo figures

See a number that looks wrong?